PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Chemists design molecules for controlling bacterial behavior

Yan-Yeung Luk, associate professor of chemistry, has spearheaded the discovery, in conjunction with his research lab at Syracuse University and the Wang Lab at SUNY Upstate Medical University

Chemists design molecules for controlling bacterial behavior
2014-05-13
(Press-News.org) Chemists in the College of Arts and Sciences have figured out how to control multiple bacterial behaviors—potentially good news for the treatment of infectious diseases and other bacteria-associated issues, without causing drug resistance. Yan-Yeung Luk, associate professor of chemistry, has spearheaded the discovery, in conjunction with his research lab at Syracuse University and the Wang Lab at SUNY Upstate Medical University. Their findings are the subject of a forthcoming article in the journal ChemBioChem (John Wiley & Sons Inc.). "Since the discovery of the first antibiotic, penicillin, in 1928, bacteria have become smarter and have developed resistance to many drugs," says Luk, an expert in bio-organic chemistry, nanomaterials and chemical biology. "They've done this by altering their genetic make-up; transferring drug-resistant genes between one another; and creating biofilms, which are multicellular communities where bacteria can be a thousand-fold more resistant to antibiotics." In response, Luk's team has developed a class of chemical agents that does not kill bacteria but, rather, changes their multicellular behaviors. These agents are called disaccharide derivatives, and they mimic a class of natural molecules known as rhamnolipids, which are produced and secreted by the bacterium itself. Luk says that while non-microbicidal (i.e., "non-killing") molecules are nothing new, his are unique because they target a new, yet-to-be-explained set of biological receptors. "Rhamnolipids modulate at least three multicellular bioactivities in Pseudomonas aeruginosa," says Luk, referring to the rod-shaped bacterium that causes disease in animals and humans. "The synthetic molecules made by our lab don't exactly look like rhamnolipids, but they can control bioactivities, such as swarming movements, surface adhesion and biofilm formation." This class, he adds, is non-microbicidal with a wide variety of microbes, thus giving it broad commercial value. It also has the potential to inhibit horizontal gene transfer—the process by which bacteria share genetic information, such as the ability to be drug-resistant. In the near future, Luk's team plans to unveil another class of molecules they have designed that not only mimics but also dominates the activities of rhamnolipids. "Rhamnolipids are already on the market, but our product, with its synthetic flexibility, has just as many applications and may be improved rationally by synthetic design," says Luk, who also holds courtesy appointments in the Department of Biology in the College of Arts and Sciences and in the Department of Biomedical and Chemical Engineering in the College of Engineering and Computer Science. "All of this is subject to ongoing research."

INFORMATION: END

[Attachments] See images for this press release:
Chemists design molecules for controlling bacterial behavior Chemists design molecules for controlling bacterial behavior 2

ELSE PRESS RELEASES FROM THIS DATE:

UCSF: E-cigarettes expose people to more than harmless vapor, should be regulated

2014-05-13
In a major scientific review of research on e-cigarettes, UC San Francisco scientists found that industry claims about the devices are unsupported by the evidence to date, including claims that e-cigarettes help smokers quit. The review marks the first comprehensive assessment of peer-reviewed published research into the relatively new phenomenon of electronic cigarettes. The devices, which are rapidly gaining a foothold in popular culture particularly among youth, are marketed as a healthier alternative to tobacco smoking, as an effective tool to stop smoking, ...

Scientists from USC and NYU design a molecule that blocks cancer growth in mice

2014-05-13
A team of researchers from USC and NYU has developed and patented a small molecule that interferes with cancer progression with minimal side effects. The molecule prevents two critical proteins from interacting by mimicking the surface topography of one protein – like wearing a mask – which tricks the other protein into binding with it. This stops a so-called "transcription factor" that controls the transcription of genetic information. That transcription factor is what would have created an aberrant gene expression, contributing to the cancer growth. Because of the ...

Scientists slow brain tumor growth in mice

Scientists slow brain tumor growth in mice
2014-05-13
Much like using dimmer switches to brighten or darken rooms, biochemists have identified a protein that can be used to slow down or speed up the growth of brain tumors in mice. Brain and other nervous system cancers are expected to claim 14,320 lives in the United States this year. The results of the preclinical study led by Eric J. Wagner, Ph.D., and Ann-Bin Shyu, Ph.D., of The University of Texas Health Science Center at Houston (UTHealth) and Wei Li, Ph.D., of Baylor College of Medicine appear in the Advance Online Publication of the journal Nature. "Our work ...

Birth by C-section, early antibiotic use put kids at risk for allergic esophagitis

2014-05-13
Children delivered by cesarean section and those given antibiotics during early infancy appear more prone to developing allergic inflammation of the esophagus — the muscular tube that connects the mouth to the stomach — according to results of a study by investigators from the Johns Hopkins Children's Center and Harvard Medical School. The findings, published online May 2 in the Journal of Allergy and Clinical Immunology: In Practice, reveal that early antibiotic treatment and C-section delivery may somehow precipitate disease development by altering a child's microbiota ...

Professional surfer back in the water after successful surgery to treat rare bone cancer

Professional surfer back in the water after successful surgery to treat rare bone cancer
2014-05-13
LOS ANGELES (May 13, 2014) – When professional surfer Richie Lovett began experiencing hip pain at 31, he attributed it to his athletic lifestyle. But after months of discomfort and preliminary tests, the Australian native learned the pain was caused by a cancerous tumor in his femur or thigh bone. "As a professional athlete, I was blindsided by the news that I had cancer," said Lovett. "I realized very quickly that cancer would have a profound effect on my life. I knew I needed an experienced oncologist to tackle this disease, so I began an international search to find ...

Quantum trimer -- from a distance

Quantum trimer -- from a distance
2014-05-13
Eight years ago Rudolf Grimm's research group was the first to observe an Efimov state in an ultracold quantum gas. The Russian physicist Vitali Efimov theoretically predicted this exotic bound state of three particles in the 1970s. He forecast that three particles would form a bound state due to their quantum mechanical properties, under conditions when a two-body bound state would be absent. What is even more astounding: When the distance between the particles is increased by factor 22.7, another Efimov state appears, leading to an infinite series of these states. Until ...

Researchers identify link between colon cancer and metabolism

2014-05-13
HEIDELBERG, 13 May 2014 – More than 60 years ago Otto Warburg recognized that cancer cells differ from normal cells in the metabolic pathway they use for the oxidation of sugar. Rather than the typical series of oxidative steps that take place in the citric acid cycle, cancer cells metabolize sugar via the glycolytic pathway irrespective of whether oxygen is present or not. In The EMBO Journal, researchers in the United States report that the reason for this difference in colon cancer is changes in the Wnt signaling pathway, an essential communication pathway operating ...

Dangerous nitrogen pollution could be halved

2014-05-13
Ambitious mitigation efforts, however, could decrease the pollution by 50 percent. The analysis is the very first to quantify this. "Nitrogen is an irreplaceable nutrient and a true life-saver as it helps agriculture to feed a growing world population – but it is unfortunately also a dangerous pollutant," says Benjamin Bodirsky, lead-author of the study. In the different forms it can take through chemical reactions, it massively contributes to respirable dust, leads to the formation of aggressive ground-level ozone, and destabilizes water ecosystems. Damages in Europe ...

Male infertility: It's all about the package

Male infertility: Its all about the package
2014-05-13
Cold Spring Harbor, NY – Infertility is generally thought of as a woman's problem. In fact, more than 3 million men across America also experience it. Today, researchers from Cold Spring Harbor Laboratory (CSHL) describe a key event during sperm development that is essential for male fertility. A team led by CSHL Professor Alea Mills explains how a protein controls DNA packaging to protect a man's genetic information. The sperm is a simple delivery vehicle for a man's genetic information. The highly specialized cell is little more than a DNA bundle powered by molecular ...

Concerns raised over EU ban on ditching unwanted fish

2014-05-13
New rules banning fishermen from throwing away unwanted fish they have caught could harm wildlife – and fail to improve fish stocks, a University of Strathclyde report has found. The study, published in the journal Nature Communications, suggests new reforms to the European Union's Common Fisheries Policy (CFP) – ending the practice of throwing away unwanted fish caught at sea – may have unintended consequences. The new CFP took effect on 1 January 2014 and will phase out the discarding of fish between 2015 and 2019. The aim is to improve fish stocks – but Professor ...

LAST 30 PRESS RELEASES:

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

[Press-News.org] Chemists design molecules for controlling bacterial behavior
Yan-Yeung Luk, associate professor of chemistry, has spearheaded the discovery, in conjunction with his research lab at Syracuse University and the Wang Lab at SUNY Upstate Medical University